Register Today for SASM's Annual Meeting for an Early Bird discount! |
Join us for this high impact meeting with experts discussing topics including post-operative respiratory monitoring, novel methods of delivering PAP therapy, wellness and sleep, and novel medications and their impact on anesthesia. Other topics include surgical evaluation and treatment of sleep apnea and pediatric sleep apnea. Additionally, we will hear from patient speakers as well as receive updates from SASM leaders related to perioperative care of patients with sleep
disorders. Our meeting will also include a hands-on workshop where participants will be able to speak with experts in sleep medicine and anesthesiology. We hope to see you there! |
|
|
Stay Up to Date with the Sleep and Anesthesia Latest Research! |
|
|
Mandibular Advancement vs Combined Airway and Positional Therapy for Snoring
A Randomized Clinical Trial
Patrick Ioerger, BS; Azadeh Afshari, DDS; Firas Hentati, MD, MSCI; William Strober, MD; Dorina Kallogjeri, MD, MPH; Yo-El Ju, MD, MSC; Jay F. Piccirillo, MD Abstract Importance Approximately 150 million individuals in the US snore in the absence of obstructive sleep apnea (primary snoring), but few studies have examined the efficacy of treatments for snoring or evaluated the effect of snoring in sleeping partners.
Objective To evaluate the efficacy of 2 treatments for primary snoring.
Design, Setting, and Participants This pilot randomized clinical trial that included a convenience sample of people who snore without sleep apnea and their sleeping partner who underwent 4 weeks of snoring treatment was conducted at an academic medical center between October 3, 2022, and July 3, 2023.
Interventions Fifty couples were randomized to either use a mandibular advancement device (MAD) or receive combined airway and positional therapy (CAPT; external nasal dilator, nasal saline lavage with mometasone, mouth taping, and lateral positional therapy).
Main Outcome and Measure Percentage of sleeping partners who reported that their partner’s snoring was either very much improved or much improved (responder) on the Clinical Global Impression of Improvement scale.
Results A total of 42 dyads completed the study; 23 (55%) were randomized to MAD and 19 (45%) to CAPT. Among people who snore, 26 (62%) were female, and the mean (SD) age was 48 (14) years. Of 23 dyads randomized to MAD, 21 people who snore (91%) were rated by the sleeping partner as a responder, while 11 of the 19 dyads (58%) randomized to CAPT were rated by the sleeping partner as responder, resulting in a difference of 33 percentage points (95% CI, 8-58) and a number needed to treat of 3. Of the 10 participants who were withdrawn, 4 were withdrawn due to adverse effects of the treatment that were evenly distributed between the MAD (n?=?2) and CAPT (n?=?2) groups.
Conclusion and Relevance The results of this randomized clinical trial showed that the MAD may be more effective than CAPT for treating primary snoring, while both treatment options were found to reduce primary snoring. Physicians should have a patient-centered discussion to determine which treatment is best for individual patients with primary snoring, weighing convenience, adverse effects, and cost as factors.
|
|
|
The Society of Anesthesia and Sleep Medicine (SASM) is excited to invite authors to submit abstracts for its 14th annual meeting this year, which will be held on October 18th in Philadelphia, PA.
The 2024 Annual Meeting will address the theme, “Monitoring the Future of Anesthesia and Sleep: Developments in Technology and Treatment."
SASM annual meeting is a good opportunity and a great platform for researchers, anesthesiologists, and sleep physicians interested in perioperative sleep medicine to meet and discuss various topics, making it different and unique.
The Abstract Subcommittee will be honoring the best abstracts with the prestigious Best Abstracts Awards. The winner will be chosen based on the scientific merit of their submissions, originality, and vision to improve the scientific understanding of anesthesia and sleep medicine and improve the quality of perioperative patient care.
Abstracts submissions now being accepted.
Deadline 11:59 PM on July 31, 2024
Acceptance notifications will be sent via email on August 30, 2024 |
|
|
|
Exhibitor and sponsorship registration is OPEN!
On behalf of the Society of Anesthesia and Sleep Medicine (SASM), we invite you to exhibit at the SASM 14th Annual Meeting: “Monitoring the future of anesthesia and sleep: developments in technology and treatment” held in Philadelphia, on October 18, 2024.
The objective of this meeting is to provide a forum for discussions pertaining to the common grounds between sleep and anesthesia. The goal is to promote excellence in medical care, research and education in anesthesia, sleep medicine and perioperative medicine.
This conference is an excellent opportunity to present your organization to a relevant and influential audience. Supporting the conference is a practical way of supporting the Society of Anesthesia and Sleep Medicine.
|
|
|
Member's Corner We look forward to your continued membership with SASM as we work together to improve the care for our patients and advance the broad body of science overlapping the disciplines of Anesthesia and Sleep Medicine. |
|
|
More information can be found on the SASM website https://www.sasmhq.org |
|
|
|
